According to a company press release, RevCore is the first mechanical thrombectomy device designed to address venous in-stent thrombosis, an increasingly common occurrence impacting more patients every year. The device includes a diameter-controlled coring element designed to engage thrombus within stents.
With RevCore, Inari has developed a solution for an entirely new patient population not currently addressed by the ClotTriever or FlowTriever platforms, the press release reports. Inari will be co-hosting a webinar with the Venous Symposium today, Wednesday 7 June at 7pm ET (4pm PT) to introduce RevCore and review the initial case experience. Register here.
“Until now, physicians have had limited options to treat patients suffering from symptoms of venous stent failure and some patients are relegated to repeated suboptimal interventions,” said Steven Abramowitz (MedStar Health, Washington, DC, USA). “RevCore is a game changer as it physically removes in-stent thrombus, restores flow, and could potentially reduce the need for additional reintervention. There are a lot of patients out there that may benefit from the RevCore procedure.”
The Triever16 Curve catheter, the latest addition to the FlowTriever platform, is purpose-built to be versatile for both pulmonary embolism and peripheral thrombectomy. The trackable catheter features a pre-shaped curve for targeted aspiration. Inari claims that Triever16 Curve offers unique advantages over 16Fr continuous aspiration catheters, including compatibility with the FlowSaver blood return system and simple access to larger, more powerful 20Fr or 24Fr catheters within the company’s price-per-procedure model.
“Triever16 Curve is an important addition to the already comprehensive Inari venous thromboembolism [VTE] toolkit,” said Angelo Marino (Yale School of Medicine, New Haven, USA). “Every VTE patient is different. With both aspiration and mechanical bloodless thrombectomy options available, including multiple sizes and shapes of large-bore aspiration catheters, we are equipped to treat nearly every VTE patient that comes in the door.”